Introduction
============

Multimorbidity defined as the co-occurrence of multiple chronic or acute diseases and medical conditions within one person is highly prevalent in the elderly.[@b1-cia-11-335] Many of the age-associated diseases are conditions that predispose to pain. However, age-banded data regarding the prevalence of pain are inconsistent. Data have been published showing that the rates of pain increase,[@b2-cia-11-335] do not change,[@b3-cia-11-335] or even decrease[@b4-cia-11-335] with age. Elderly subjects and their caregivers often believe that pain is a feature of normal aging and therefore they do not report it.[@b5-cia-11-335]

There is no doubt that pain is underrecognized among elderly nursing home residents. Cohen-Mansfield et al[@b6-cia-11-335] identified several staff-related barriers to intervention for pain in nursing homes. The most frequent staff-related barrier (concerning 24% of residents) was the physician concluding that the patient had no pain despite the detection of pain through formal assessment or observation. Underrecognition of pain is very common even in nursing home residents with cancer. Just recently, Pimentel et al[@b7-cia-11-335] showed that daily pain was present in two-thirds of nursing home residents with cancer in the USA and almost one in every five of them received no analgesics. The frequency of pain in European long-term care facilities varied between 32% and 57%; in all countries cognitive impairment was correlated with less frequency of pain[@b8-cia-11-335] and less frequency of pain treatment.[@b9-cia-11-335]

The detection of pain is a real challenge in subjects with dementia partly due to atypical presentation of pain in this group. These patients often are not able to communicate verbally, and thus pain might be expressed mainly via behavioral changes and/or psychiatric symptoms. It has been found that socially inappropriate behaviors, abnormal thought processes, and delusions are more common in nursing home residents with cognitive impairment, in whom pain was present[@b10-cia-11-335] than in those without pain. Clinicians may misinterpret these symptoms and fail to proceed with further pain-diagnosing and prescribe analgesics.[@b9-cia-11-335] There is evidence showing that pain treatment in nursing home residents with moderate-to-severe dementia significantly increases independent daily living activities[@b11-cia-11-335] and decreases the frequency of behavioral problems.[@b12-cia-11-335] The behavioral and psychological symptoms of dementia (such as agitation, aberrant motor behavior, anxiety, elation, irritability, depression, apathy, disinhibition, delusions, hallucinations, and sleep or appetite changes) affect up to 90% of all dementia subjects over the course of their illness[@b13-cia-11-335] and pain may strongly contribute to the occurrence and persistence of these symptoms.[@b12-cia-11-335]

The aim of the study was to assess analgesic use among nursing home residents and to delineate the putative associations between pain management and cognitive functions of elderly persons. To the best of our knowledge, this is the first study to assess pain management in nursing home residents in Poland.

Materials and methods
=====================

Participants
------------

Three hundred and ninety-two nursing home residents aged 75 years and above were included in the study. The subjects (or their representatives) gave their consent after receiving a full explanation of the nature of the study.

Study procedure
---------------

The project was approved by the National Committee for Scientific Research. The residents' medical files related to diagnoses and drug prescriptions were analyzed by the external researcher. Subsequently, the screening of cognitive functions was performed using the Mini-Mental State Examination (MMSE).

The analysis of residents' medical files
----------------------------------------

In each resident, the diagnoses were analyzed and the potentially pain-related diagnoses were selected, including deep vein thrombosis, rheumatoid arthritis, osteoarthritis, back pain, and pressure ulcers.[@b5-cia-11-335],[@b14-cia-11-335]

The quantitative analysis of pharmacotherapy included calculation of the number of drugs consumed by each individual. For the purpose of the qualitative analysis, all drugs used by the studied residents were coded based on the Anatomical Therapeutic Chemical classification system.[@b15-cia-11-335] Particular attention was paid to analgesic drugs, which were divided based on the analgesic ladder. Among subjects treated with nonsteroidal anti-inflammatory drugs (NSAIDs), screening for contraindications including stomatitis, bleeding disorders, congestive heart failure, kidney insufficiency, and hypertension was performed.[@b16-cia-11-335]

Prevalence of analgesic use was analyzed in three categories: regular use, pro re nata (PRN), and their combination. Coanalgesics taken by 6.4% participants were not included in the detailed analysis of pain treatment. Due to the heterogeneity of different classes of coanalgesics, some of them could have been prescribed due to different diagnoses, not necessarily for pain treatment.[@b17-cia-11-335]

Cognitive screening
-------------------

Cognitive functions were assessed with MMSE.[@b18-cia-11-335] The results were corrected for age and education.[@b19-cia-11-335] The MMSE is a screening test for cognitive impairment, assessing orientation, memory, language, attention, calculation, and ability to follow simple verbal and written commands. Although it is not a diagnostic tool for dementia as such, its results may suggest dementia. The maximum score is 30, with lower scores representing poorer performance. A result of 24--30 points meant no dementia (group A), result of 20--23 points -- mild dementia (group B), 10--19 points -- moderate dementia (group C), and 0--9 points -- severe dementia (group D).

Statistical analysis
--------------------

To evaluate the normality of distribution of the variables, the Shapiro--Wilk test was applied. As most of the investigated variables were not normally distributed, nonparametric tests were employed. Between-group differences were assessed by Fisher's exact test due to small sample size. All results were expressed as mean ± standard deviation, as well as medians. Statistical significance was set at *P*\<0.05 for all analyses.

Results
=======

The characteristics of the study group are presented in [Table 1](#t1-cia-11-335){ref-type="table"}.

Characteristics of pain treatment in nursing home residents
-----------------------------------------------------------

One hundred and thirteen residents (28.8% of all studied subjects) received analgesic treatment. Among them, 84 (21.4% of all studied subjects) used them regularly, 25 (6.4%) -- PRN, and four (1.0%) -- both regularly and PRN.

Routine pain treatment
----------------------

Non-opioid analgesics were taken regularly by 53 residents. Only two subjects were taking acetaminophen and 51 NSAIDs. Among subjects treated with NSAIDs, three were taking concomitantly two different NSAIDs (meloxicam and ketoprofen, diclofenac, and ketoprofen; and ibuprofen and naproxen). Among subjects regularly taking NSAIDs, 22 were diagnosed with hypertension (33.3% of subjects treated with NSAIDs), 14 (21.2%) with congestive heart failure, two (3.0%) with esophageal reflux, and one (1.5%) with kidney insufficiency.

In regular therapy, weak opioids were only represented by tramadol: nine subjects were treated with tramadol in monotherapy. Additionally, three individuals received a combination preparation of tramadol and acetaminophen (one therapeutic formula). One subject was routinely treated with morphine. Detailed qualitative characteristics of pain treatment regarding MMSE results are presented in [Table 2](#t2-cia-11-335){ref-type="table"}. The number of subjects who were not receiving any pain treatment was higher among those with MMSE between 0 and 9 points than in those with MMSE between 24 and 30 points (*P*=0.0151).

PRN pain treatment
------------------

Non-opioid analgesics were taken PRN by 16 individuals. Among them, five were taking acetaminophen and eleven were taking NSAIDs. Tramadol was taken PRN by one resident and in a combination preparation with acetaminophen by three residents. Four residents were prescribed both regular and PRN pain medications.

As per the subgroups based on the MMSE results, we found that PRN pain treatment was prescribed to four subjects in group A, three in group B, eight in group C, and ten in group D. The prevalence of PRN pain treatment did not differ between the groups.

Discussion
==========

To the best of our knowledge, this is the first study to assess pain management in residents of nursing homes in Poland.

The prevalence of pain treatment in our study was very low. Only one out of three analyzed subjects received any analgesic drug and only one out of five received a routine scheduled treatment. Analgesic medication was routinely received by one out of four subjects without dementia and only one out of ten with severe dementia. These numbers are much lower compared with data from other countries, where the prevalence of pain treatment with at least one analgesic ranges between 38.8% and 79.6% in subjects with no dementia and between 20.2% and 61.2% in those with dementia.[@b17-cia-11-335],[@b20-cia-11-335],[@b21-cia-11-335]

These differences do not remain fully elucidated. They may be attributed to the heterogeneity of nursing home residents and care management, which is associated with the detection of pain. Nevertheless, in spite of the differences in prevalence of the use of analgesics, a common phenomenon is observed: residents with dementia are less likely to be treated with analgesic drugs than nondemented ones. While pain perception and processing are not diminished in dementia, patients' ability to express pain diminishes as they lose the ability to communicate pain verbally.[@b22-cia-11-335] Moreover, typical pain behaviors (behaviors indicating the presence of pain) also decrease with the progress of dementia. In elderly with severe dementia, an atypical presentation of pain occurs (eg, body movement, changes in behavior), which may be underrecognized, leading to inappropriate pain treatment. In these patients, neuroleptics are used to control pain-related behavioral and psychological symptoms.

In our study, while the prevalence of analgesic use in residents with moderate and severe dementia was relatively low, they were more likely to take neuroleptics than subjects without or with mild symptoms of dementia.

In our study, almost one out of ten subjects with severe dementia was given analgesics PRN. It must be underlined that although PRN pain treatment is believed to be adequate in cognitively intact residents, in those with moderate or severe dementia, who cannot advocate for themselves, such therapeutic approach is inappropriate and scheduled medications are recommended.[@b23-cia-11-335]

According to current recommendations, acetaminophen is the first-line treatment in chronic pain management in elderly subjects.[@b24-cia-11-335] However, in our analysis, only two (2.4% of those regularly treated with any analgesic) were treated with acetaminophen in monotherapy. Low use of acetaminophen has also been shown by Kölzsch et al,[@b25-cia-11-335] who studied nursing home residents in Germany. They have suggested that this may be due to the lack of reimbursement of acetaminophen in outpatient care in Germany. Also in Poland, the drug reimbursement system does not cover acetaminophen. However, insufficient knowledge of the long-term safety and efficacy of acetaminophen should also be taken into consideration.[@b26-cia-11-335] It is in agreement with another observation regarding high consumption of NSAIDs in our study. Based on the guidelines, these drugs should be used only for a short time, even in subjects with no contraindications.[@b27-cia-11-335] In our study, several residents were taking two NSAIDs at a time. There is no rationale behind duplicating any substances from the same therapeutic class as the risk of side effects significantly increases with no positive influence on the therapeutic effect. A high frequency of duplicate treatment with drugs from the same therapeutic class has also been shown for other drugs.[@b27-cia-11-335],[@b28-cia-11-335] Additionally, we also found subjects taking NSAIDs regardless of contraindications, most commonly represented by hypertension. It is well known that NSAIDs may both induce and exacerbate hypertension and thus result in the "prescribing cascade".[@b29-cia-11-335] Moreover, it has been shown that hypertension is a risk factor for cognitive impairment and thus it may lead to deterioration of functional independence.[@b30-cia-11-335]

In our study, while the prevalence of analgesic use in residents with moderate and severe dementia was relatively low, they were more likely to take neuroleptics than subjects without dementia or with mild dementia according to MMSE (data not shown). Pain is often undetected or misinterpreted in people with dementia in residential aged care facilities, particularly those with communication difficulties.[@b31-cia-11-335] It causes discomfort and distress and is frequently the underlying cause of behavioral symptoms, which can lead to inappropriate treatment with antipsychotic medications.[@b32-cia-11-335]

The main limitation of our study was the lack of pain assessment. It must be pointed out that pain detection is not part of the routine assessment in nursing home residents in Poland. At the national level, there is no standardized protocol for collecting information on patients' needs in long-term care facilities. Since our study was only based on data obtained from the existing nursing files, pain assessment is missing. An analysis of analgesic use in nursing home residents without pain assessment has also been conducted by another group.[@b33-cia-11-335] Additionally, the limitations of MMSE must also be taken into account. But still, it was shown that other tests have even more limited evidence in detecting dementia compared with MMSE.[@b34-cia-11-335] Thus, apart from its limitations, MMSE is still the most frequently used brief instrument for the cognitive screening,[@b35-cia-11-335],[@b36-cia-11-335] hence, we decided to use it in our study.

Conclusion
==========

Our paper demonstrated a significantly low use of analgesics in nursing home residents in Poland. Raising awareness regarding the consequences of underrecognition and undertreatment of pain among health professionals is therefore necessary.

There is a need to introduce pain evaluation as a routine element of geriatric assessment in nursing homes.
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###### 

Characteristics of study group

  Characteristic                            Mean ± standard deviation   Median; range
  ----------------------------------------- --------------------------- ---------------
  Age (years)                               83.6±5.9                    83; 75--102
  Length of institutionalization (months)   64.4±64.4                   43; 1--303
  Number of diagnoses                       2.5±1.3                     2; 0--6
  Number of used drugs                      5.5±3.0                     5; 0--13
  MMSE (points)                             15.4±9.3                    17; 0--30

**Abbreviation:** MMSE, Mini-Mental State Examination.

###### 

Characteristics of regular pain treatment with respect to the MMSE results -- group A MMSE results 24--30 points, group B (20--23 points), group C (10--19 points), group D (0--9 points)

  Characteristic                                       Group A n=82   Group B n=67   Group C n=144           Group D n=99
  ---------------------------------------------------- -------------- -------------- ----------------------- -----------------------
  MMSE (points)                                        24--30         20--23         10--19                  0--9
  No analgesics prescribed                             62 (75.6%)     55 (82.1%)     122 (84.7%)             89 (89.9%)
                                                                                     *P*=0.1097 vs group A   *P*=0.0151 vs group A
  Routine step 1 (non-opioid)                                                                                
  Acetaminophen                                        0              0              1 (0.7%)                1 (1.0%)
  NSAIDs                                               16 (19.5%)     12 (17.9%)     17 (11.8%)              6 (6.1%)
                                                                                     *P*=0.1808 vs group A   *P*=0.0233 vs group A
  Routine step 2 − tramadol (weak opioids)             2 (2.4%)       0              4 (2.8%)                3 (3.0%)
  Routine step 3 − morphine (strong opioid)            0              0              0                       1 (1.0%)
  Acetaminophen + tramadol (one therapeutic formula)   2 (2.4%)       0              1 (0.7%)                0

**Abbreviations:** MMSE, Mini-Mental State Examination; NSAIDs, nonsteroidal anti-inflammatory drugs.
